Standard Life reported a 25% increase in adjusted operating profit for the first half of 2026, reaching £563 million versus £451 million a year earlier. The insurer said cash generation rose 6% to £745 million, while total cash generation hit £900 million, up from £784 million in the comparable period.
The Solvency II leverage ratio improved to 29% at the end of June, meeting its 30% target ahead of schedule, and the shareholder capital coverage ratio stood at 169% within its 140%–180% range. The group recorded a Solvency II surplus of £3.2 billion. Recurring management actions contributed £318 million, and cost‑saving initiatives delivered £210 million of the £250 million run‑rate target.
An interim dividend of 28.05 pence per share was declared, a 2.6% increase, while the parent’s distributable reserves were £5.8 billion. Shares fell 2.04% to $0.96 after the results.
The company’s Aegon UK acquisition, valued at £2 billion, is slated for completion around year‑end 2026. Funding includes £750 million in cash and 181.1 million newly issued Standard Life shares, giving Aegon a 15.3% stake in the combined entity. The deal is expected to create £800 million of net synergies and lift the contribution of capital‑light businesses to operating profit from 47% to 57% on a pro‑forma 2025 basis. In July, Standard Life issued £350 million of fixed‑rate restricted Tier 1 notes to finance part of the cash consideration.
A pension‑risk‑transfer partnership is set to launch in H1 2027, backed by up to £2 billion from CVC Capital Partners, Prudential Financial, Goldman Sachs and MS&AD Insurance Group Holdings. Standard Life will retain a 25% ownership while the partners provide the remaining capital.
The insurer also repaid £500 million of debt in June, consisting of $350 million in Tier 2 notes and £250 million in Tier 3 notes. A strategic update is scheduled for November 2026.
